A role for Src kinase in progestin facilitation of estrous behavior in estradiol-primed female rats

Hormones and Behavior

Volumn 58, Issue 2, 2010, Pages 223-229

  González Flores, Oscar ^a   Beyer, Carlos ^a   Gómora Arrati, Porfirio ^a   García Juárez, Marcos ^a   Lima Hernández, Francisco J ^a   Soto Sánchez, Alfonso ^a   Etgen, Anne M ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

5 dihydroprogesterone; 5 pregnan,3 20 dione; Estradiol; Lordosis behavior; MAPK; PP2; Progesterone; Progesterone metabolism; Src kinase

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 5ALPHA PREGNANE 3,20 DIONE; ESTRADIOL; GESTAGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROTEIN TYROSINE KINASE; RAF PROTEIN; ELTANOLONE; ENZYME INHIBITOR; PYRIMIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTRUS; FEMALE; HORMONE SENSITIVITY; LORDOSIS QUOTIENT; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROCEPTIVE BEHAVIOR; PROTEIN FUNCTION; RAT; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; ZONA INCERTA; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; DRUG EFFECTS; ESTRUS CYCLE; HYPOTHALAMUS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

5-ALPHA-DIHYDROPROGESTERONE; ANIMALS; ENZYME INHIBITORS; ESTRADIOL; ESTROUS CYCLE; FEMALE; HYPOTHALAMUS; MODELS, NEUROLOGICAL; OVARIECTOMY; PREGNANOLONE; PROGESTERONE; PROGESTINS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEXUAL BEHAVIOR, ANIMAL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TIME FACTORS;

EID: 77953356644     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2010.03.014     Document Type: Article

References (60)

1. Ballare C., Uhrig M., Bechtold T., Sancho E., Di Domenico M., Migliaccio A., Auricchio F., Beato M. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol. Cell. Biol. 2003, 23:1994-2008.
2. Barfield R.J., Glaser J.H., Rubin B.S., Etgen A.M. Behavioral effects of progestin in the brain. Psychoneuroendocrinology 1984, 9:217-231.
3. Beyer C., González-Mariscal G. Elevation in hypothalamic cyclic AMP as a common factor in the facilitation of lordosis in rodents: a working hypothesis. Ann. N. Y. Acad. Sci. 1986, 474:270-281.
4. Beyer C., González-Mariscal G., Eguíbar J.R., Gómora P. Lordosis facilitation in estrogen-primed rats by intrabrain injection of pregnanes. Pharmacol. Biochem. Behav. 1989, 31:919-926.
5. Beyer C., González-Flores O., González-Mariscal G. Ring A reduced progestins potently stimulate estrous behavior in rats: paradoxical effect through the progesterone receptor. Physiol. Behav. 1995, 58:985-993.
6. Beyer C., Gonzalez-Flores O., Garcia-Juarez M., Gonzalez-Mariscal G. Non-ligand activation of estrous behavior in rodents: cross-talk at the progesterone receptor. Scand. J. Psychol. 2003, 44:221-229.
7. Blackmore P.F. Progesterone metabolites rapidly stimulate calcium influx in human platelets by a src-dependent pathway. Steroids 2008, 73:738-750.
8. Blaustein J.D. Progestin receptors: neuronal integrators of hormonal and environmental stimulation. Ann. N. Y. Acad. Sci. 2003, 1007:238-250.
9. Boonyaratanakornkit V., Scott M., Ribon V., Sherman L., Anderson S., Maller J., Miller W., Edwards D.A. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinase. Mol. Cell. 2001, 8:269-280.
10. Boonyaratanakornkit V., McGowan E.J., Sherman L., Mancini M.A., Cheskis B.J., Edwards D.P. The role of extra-nuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and cell cycle. Mol. Endocrinol. 2007, 21:359-375.
11. Computational Handbook of Statistics 1987, Foresman and Company, London. J.L. Bruning, B.L. Kintz (Eds.).
12. Celotti F., Melcangi R.C., Martini L. The 5 alpha-reductase in the brain: molecular aspects and relation to brain function. Front. Neuroendocrinol. 1992, 13:163-215.
13. Cheng Y.J., Karavolas H.J. Conversion of prosterone to 5α-pregnane-3, 20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medial basal hypothalamus and the effect of estradiol and stage of estrous cycle on the conversion. Endocrinology 1973, 93:1157-1162.
14. Chu H.P., Morales J.C., Etgen A.M. Cyclic GMP may potentiate lordosis behaviour by progesterone receptor activation. J. Neuroendocrinol. 1999, 11:107-113.
15. Collado M.L., Rodríguez-Manzo G., Cruz M.L. Effect of progesterone upon adenylate cyclase activity and cAMP levels in brain areas. Pharmacol. Biochem. Behav. 1985, 23:501-504.
16. Edwards D.P. Regulation of signal transduction pathways by estrogen and progesterone. Annu. Rev. Physiol. 2005, 67:335-376.
17. Etgen A.M. Progestin receptor and the activation of female reproductive behavior: a critical review. Horm. Behav. 1984, 18:411-430.
18. Etgen A.M. Intrahypothalamic implants of noradrenergic antagonists disrupt lordosis behavior in female rats. Physiol. Behav. 1990, 48:31-36.
19. Etgen A.M., Acosta-Martinez M. Participation of growth factor signal transduction pathways in estradiol facilitation of female reproductive behavior. Endocrinology 2003, 144:3828-3835.
20. Etgen A.M., Barfield R.J. Antagonism of female sexual behavior with intracerebral implants of antiprogestin RU 38486: correlation with binding to neural progestin receptors. Endocrinology 1986, 119:1610-1617.
21. Faivre E.J., Lange C.A. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol. Cell. Biol. 2007, 27:466-480.
22. Frye C.A., Walf A.A. In the ventral tegmental area, the membrane-mediated actions of progestins for lordosis of hormone-primed hamsters involve phospholipase C and protein kinase C. J. Neuroendocrinol. 2007, 19:717-724.
23. Frye C.A., Walf A.A. Membrane actions of progestins at dopamine type 1-like and GABAA receptors involve downstream signal transduction pathways. Steroids 2008, 73(9-10):906-913. (Oct).
24. Glaser J.H., Rubin B.S., Barfield R.J. Onset of the receptive and proceptive components of feminine sexual behavior in rats following the intravenous administration of progesterone. Horm. Behav. 1983, 17:18-27.
25. Glaser J.H., Etgen A.M., Barfield R.J. Intrahypothalamic effects of progestin agonists on estrous behavior and progestin receptor binding. Physiol. Behav. 1985, 34:871-877.
26. González-Flores O., Etgen A.M. The nitric oxide pathway participates in estrous behavior induced by progesterone and some of ring A-reduced metabolites. Horm. Behav. 2004, 45:50-57.
27. González-Flores O., Shu J., Camacho Arroyo I., Etgen A.M. Regulation of lordosis by cyclic 3,5-guanosine monophosphate, progesterone, and its 5α-reduced metabolites involves mitogen-activated protein kinase. Endocrinology 2004, 145:5560-5567.
28. González-Flores O., Ramírez-Orduña J.M., Lima-Hernandez F.J., Garcia-Juarez M., Beyer C. Differential effect of kinase A and C blockers on lordosis facilitation by progesterone and its metabolites in ovariectomized estrogen-primed rats. Horm. Behav. 2006, 49:398-404.
29. González-Flores O., Etgen A.M., Komisaruk B.K., Gómora-Arrati P., Macias-Jimenez A., Lima-Hernández F.J., Garcia-Juárez M., Beyer C. Antagonists of the protein kinase A and mitogen-activated protein kinase systems and of the progestin receptor block the ability of vaginocervical/flank-perineal stimulation to induce female rat sexual behaviour. J. Neuroendocrinol. 2008, 20:1361-1367.
30. González-Mariscal G., González-Flores O., Beyer C. Intrahypothalamic injection of RU486 antagonizes the lordosis induced by ring A-reduced progestins. Physiol. Behav. 1989, 46:435-438.
31. Guerra-Araiza C., Amorim M.A., Pinto-Almazan R., González-Arenas A., Campos M.G., García-Segura L.M. Regulation of the phosphoinositide-3 kinase and mitogen-activated protein kinase signaling pathways by progesterone and its reduced metabolites in the rat brain. J. Neurosci. Res. 2009, 87:470-481.
32. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 1996, 271:695-701.
33. Hou X.Y., Liu Y., Zhang G.Y. PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia. Neurosci. Lett. 2007, 420:235-239.
34. Kalia L.V., Gingrich J.R., Salter M.W. Src in synaptic transmission and plasticity. Oncogene 2004, 23:8007-8016.
35. Karavolas H.J., Bertics P.J., Hodges D., Rudie N. Progesterone processing by neuroendocrine structures. Metabolism of Hormonal Steroids in the Neuroendocrine Structures 1984, 149-170. Raven Press, New York. F. Celotti, F. Naftolin, L. Marini (Eds.).
36. Kow L.M., Pfaff D.W. The membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12354-12357.
37. Kow L.M., Brown H.E., Pfaff D.W. Activation of protein kinase C in the hypothalamic ventromedial nucleus or the midbrain central gray facilitates lordosis. Brain Res. 1994, 660:241-248.
38. Lange C.A., Shen T., Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1032-1037.
39. Leonhardt S.A., Boonyaratanakornkit V.V., Edwards D.P. Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids 2003, 68:761-770.
40. Levine J.E., Chappell P.E., Schneider J.S., Sleiter N.C., Szabo M. Progesterone receptors as neuroendocrine integrators. Front. Neuroendocrinol. 2001, 22:69-106.
41. Li Z., Hosoi Y., Cai K., Tanno Y., Matsumoto Y., Enomoto A., Morita A., Nakagawa K., Miyagawa K. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation. Biochem. Biophys. Res. Commun. 2006, 341:363-368.
42. Mani S.K., Blaustein J.D., O'Malley B.W. Progesterone receptor function from a behavioral perspective. Horm. Behav. 1997, 31:244-255.
43. Mani S.K., Fienberg A.A., O'Callaghan J.P., Snyder G.L., Allen P.B., Dash P., Moore A.N., Mitchell A.J., Bibb J., Greengard P., O'Malley B.W. Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice. Science 2000, 287:1053-1056.
44. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., Gong W., Beato M., Auricchio F. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 1998, 17:2008-2018.
45. Parsons S.J., Parsons J.T. Src family kinases, key regulators of signal transduction. Oncogene 2004, 23:7906-7909.
46. Parsons B., Rainbow T.C., MacLusky N.J., McEwen B.S. Progestin receptor levels in rat hypothalamic and limbic nuclei. J. Neurosci. 1982, 2:1446-1452.
47. The Rat Brain in Stereotaxic Coordinates 2006, Academic Press, Australia. G. Paxinos, C. Watson (Eds.).
48. Petralia S.M., Walf A.A., Frye C.A. In the ventral tegmental area, progestins' membrane-mediated actions for lordosis of hamsters and rats involve protein kinase A. Neuroendocrinology 2006, 84:405-414.
49. Qiu M., Olsen A., Faivre E., Horwitz K.B., Lange C.A. Mitogenactivated protein kinase regulates nuclear association of human progesterone receptors. Mol. Endocrinol. 2003, 17:628-642.
50. Raynaud J.R., Ojasoo T., Pottier J., Salmon J. Chemical substitution of steroid hormones: effect on receptor binding and pharmacokinetics. Biochemical Actions of Hormones 1982, 305-342. Academic Press, New York. G. Litwack (Ed.).
51. Revelli A., Massobrio M., Tesarik J. Nongenomic actions of steroid hormones in reproductive tissues. Endocr. Rev. 1998, 19:3-17.
52. Rubin B.S., Barfield R.J. Progesterone in the ventromedial hypothalamus facilitates estrous behavior in ovariectomized, estrogen-primed rats. Endocrinology 1983, 113:797-804.
53. Rupprecht R., Reul J.M.H.M., Trapp T., Van Steensel B., Wetzel C., Datum K., Zieglgäsberger W., Holsboer F. Progesterone receptor-mediated effects of neuroactive steroids. Neuron 1993, 11:523-530.
54. Shen T., Horwitz K.B., Lange C.A. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol. Cell. Biol. 2001, 21:6122-6131.
55. Smith H.E., Smith R.G., Toft D.O., Neergaard J.R., Burrows E.P., O'Malley B.W. Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. J. Biol. Chem. 1974, 249:5924-5932.
56. Vasudevan N., Kow L.M., Pfaff D. Integration of steroid hormone initiated membrane action to genomic function in the brain. Steroids 2005, 70:388-396.
57. Watson C.S., Gametchu B. Membrane-initiated steroid actions and the proteins that mediate them. Proc. Soc. Exp. Biol. Med. 1999, 220:9-19.
58. Wehling M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 1997, 59:365-393.
59. Whalen R.E., Lauber A.H. Progesterone substitutes: cGMP mediation. Neurosci. Biobehav. Rev. 1986, 10:47-53.
60. Whalen R.E., Yahr P., Luttge W.G. The role of the metabolism in hormonal control of sexual behavior. Handbook of Behavioral Neurobiology 1985, 609-663. Plenum Press, New York and London. N. Adler, D.W. Pfaff, R.W. Goy (Eds.).